Estado actual de la pesquisa neurometabólica neonatal

Translated title of the contribution: Updating neonatal neurometabolic screening

Israel Alfonso, Gustavo Charria, Oscar Papazian

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


The purpose of neurometabolic screening is the earliest possible detection of treatable disorders. The disorders currently offered to general population screening are phenylketonuria, congenital hypothyroidism, galactosemia, congenital adrenal hyperplasia, cystic fibrosis, biotinidase deficiency, maple syrup urine disease, sickle cell disease, homocystinuria. The methods used for these evaluations are mass spectroscopy and genetic testing.

Translated title of the contributionUpdating neonatal neurometabolic screening
Original languageSpanish
Pages (from-to)36-40
Number of pages5
Issue number1 PART 1
StatePublished - Jan 1 2009


  • Neonates
  • Screening

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Updating neonatal neurometabolic screening'. Together they form a unique fingerprint.

Cite this